文献速递角膜与眼表疾病

移植物抗宿主病相关干眼:眼表黏蛋白的作用与瑞巴派特的效果

Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究采用同种异体移植小鼠模型(C57BL/6 供体、B6D2F1 受体)诱导眼部移植物抗宿主病(GVHD),发现眼部 GVHD 导致泪膜体积显著减少、角膜病变出现、角膜糖萼面积与厚度显著下降、杯状细胞显著减少以及黏蛋白 4 和 5AC 水平显著降低。局部使用黏蛋白促分泌剂瑞巴派特可部分减轻眼部 GVHD 介导的泪膜体积下降,并显著降低角膜病变的严重程度。

要点

  • 眼部 GVHD 可损害眼表糖萼与黏蛋白,黏蛋白 4 和 5AC 水平显著降低。
  • 瑞巴派特局部点眼可部分减轻眼部 GVHD 所致泪膜体积下降。
  • 瑞巴派特可显著降低眼部 GVHD 相关角膜病变的严重程度。

核心结论

  • 眼部 GVHD 对眼表糖萼和黏蛋白有不利影响。
  • 瑞巴派特可部分预防眼部 GVHD 相关泪膜减少,并降低角膜病变严重程度。

研究设计与样本

  • 采用同种异体移植小鼠模型诱导眼部 GVHD,C57BL/6 为供体、B6D2F1 为受体小鼠。
  • 用酚红棉线法和荧光素染色定量泪液分泌与角膜病变。
  • 同种异体移植后 8 周取角膜行糖萼染色与共聚焦显微镜检查,用高碘酸-希夫染色检测杯状细胞。
  • 用 ELISA 和实时 PCR 定量角膜与泪膜中黏蛋白 1、4、16、19 和 5AC 水平。
  • 瑞巴派特每日两次局部点眼。

主要发现

  • 同种异体移植导致眼部 GVHD 相关干眼,表现为泪膜体积显著减少和角膜病变出现。
  • 眼部 GVHD 导致角膜糖萼面积和厚度显著下降。
  • 杯状细胞显著减少,黏蛋白 4 和 5AC 水平也显著降低。
  • 局部瑞巴派特治疗部分减轻眼部 GVHD 介导的泪膜体积下降,并显著降低角膜病变严重程度。

临床怎么用

  • 提示眼表糖萼与黏蛋白参与眼部 GVHD 相关干眼的发病过程。
  • 瑞巴派特局部点眼在动物模型中显示可部分改善泪膜并减轻角膜病变,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The present study was designed to investigate the role of ocular surface glycocalyx and mucins in graft versus host disease (GVHD)-associated dry eye. The ameliorative effect of topical rebamipide, a mucin secretagogue, on GVHD-associated dry eye was also tested. METHODS: A mouse model of allogeneic transplantation was used to induce ocular GVHD with C57BL/6 as donors and B6D2F1 as recipient mice. Phenol red thread method and fluorescein staining was used to quantify tear secretion and corneal keratopathy. At 8 weeks after the allogeneic transplantation, corneas were harvested to perform glycocalyx staining and confocal microscopy. Goblet cell staining was performed using periodic acid Schiff's staining. Corneal and tear film levels of Mucin 1, 4, 16, 19, and 5AC were quantified using ELISA and real-time PCR. Rebamipide was applied topically twice daily to mice eyes. RESULTS: Allogeneic transplantation resulted in ocular GVHD-associated dry eye characterized by a significant decrease in tear film volume and the onset of corneal keratopathy. Ocular GVHD caused a significant decrease in the area and thickness of corneal glycocalyx. A significant decrease in the goblet cells was also noted. A significant decrease in mucin 4 and 5AC levels was also observed. Topical treatment with rebamipide partially attenuated ocular GVHD-mediated decrease in tear film volume and significantly reduced the severity of corneal keratopathy. CONCLUSIONS: Ocular GVHD has detrimental impact on ocular surface glycocalyx and mucins. Rebamipide, a mucin secretagogue, partially prevents ocular GVHD-associated decrease in tear film and reduces the severity of corneal keratopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Shamloo K, Barbarino A, Alfuraih S, et al. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue. Invest Ophthalmol Vis Sci. 2019. PMID: 31675422. doi:10.1167/iovs.19-27843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。